Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults
Status:
Recruiting
Trial end date:
2021-11-28
Target enrollment:
Participant gender:
Summary
This is a pilot study to test the efficacy of the anti-inflammatory drug (Fisetin) in
reducing inflammatory factors in blood in elderly adults and to test the efficacy of the drug
(Fisetin) in reducing frailty and markers of inflammation, insulin resistance, and bone
resorption in elderly adults.